However, further analysis via KM plotter database indicated that high levels of PRDX1 showed no effect on OS or PFS among all ovarian cancer patients, serous ovarian cancer patients, or endometrioid ovarian cancer patients. Here, PRDX1 is linked to ovarian endometrioid adenocarcinoma.